Test Price
2,800 AED✅ Home Collection Available
ATP6AP2 Gene (Parkinsonism with Spasticity, X-Linked) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATP6AP2 (الباركنسونية والتشنج المرتبط بالكروموسوم X) في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي 2026
الملخص التنفيذي: تشخيص جيني مُعمَّق لطفرة جين ATP6AP2 المرتبطة بحركات باركنسونية وتشنج وراثي مرتبط بالكروموسوم X. نضمن دقة تشخيصية فائقة بنسبة 99.9% عبر معالجة معتمدة بمعيار الآيزو 9001:2015، مع سحب منزلي بارد السلسلة، ودعم في تفسير النتائج بعد الفحص، وتحقق مباشر من التغطية التأمينية عبر واتساب +971 54 548 8731.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: Paid Hospital-Grade Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed Neurologist for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 (support available in Arabic and English).
Test Overview
This Genetic Test screens the ATP6AP2 gene for pathogenic variants responsible for a rare X-linked neurological disorder combining parkinsonism and spasticity, enabling precise diagnosis and carrier identification. يُعد هذا الفحص الجيني المتقدم أداة تشخيصية محورية للكشف عن طفرة جين ATP6AP2 المرتبط باضطراب عصبي وراثي ناتج عن طفرة الكروموسوم X.
| Feature | Our ATP6AP2 NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Diagnostic Precision | 100% exon coverage & CNV analysis for ATP6AP2; analytical sensitivity >99.9% | Multigene analysis; variant classification may require additional filtering |
| Methodology | Targeted NGS on Illumina platform, validated per ISO 9001:2015 | Non-targeted exome capture; secondary findings may increase incidental discovery risk |
| Turnaround Time | 3 to 4 Weeks | 6–12 Weeks (varies) |
| Clinical Support | Post-test telehealth with a DHA neurologist included | Often outsourced to third-party genetics services |
Physician Insight & Safety Protocol
“With over two decades in clinical neurology, I understand how genetics can illuminate a difficult diagnostic journey. This test must be correlated with your full clinical picture, imaging, and a thorough family pedigree — a negative or positive result is only one piece of the puzzle. I urge all patients to proceed with the mandatory genetic counseling to truly benefit from this powerful information.” — Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Important: Do not discontinue prescribed medication (e.g., levodopa, baclofen) without consulting your treating physician. Genetic results do not replace ongoing symptomatic management.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent or unwilling to complete pre-test genetic counselling.
- Exclusion: Patients with untreated severe coagulopathy if blood draw is the only available collection mode (we also accept saliva/extracted DNA).
- ER Red Flag: Sudden worsening of spasticity leading to repeated falls, respiratory difficulty, or inability to swallow — seek immediate emergency care regardless of test result.
- ER Red Flag: Appearance of new neuropsychiatric symptoms (psychosis, confusion) that could indicate rapid disease progression.
Patient FAQ & Clinical Guidance
Q1: What exactly does the ATP6AP2 gene test diagnose?
First-line answer: It identifies pathogenic DNA variants in the ATP6AP2 gene causing X-linked parkinsonism with spasticity, supporting definitive diagnosis when clinical signs are unclear.
يُحدد هذا الاختبار طفرات جين ATP6AP2 المسببة لمرض الباركنسونية والتشنج الوراثي المرتبط بالكروموسوم X، مما يؤكد التشخيص الدقيق للمرضى المصابين أو الناقلين للطفرة.
Q2: How is the sample collected and what is the process?
First-line answer: We use a simple blood draw or FTA card spot, transport it via ISO-certified cold chain, and analyze DNA with Next Generation Sequencing in our UAE lab.
يتم سحب عينة دم بسيطة أو نقطة دم على بطاقة حفظ، وتُنقل بسلسلة تبريد معتمدة إلى مختبرنا في الإمارات، حيث يُحلل الحمض النووي بتقنية التسلسل عالي الإنتاجية (NGS).
Q3: Is the covered by UAE health insurance?
First-line answer: Many UAE insurers include genetic testing for inherited neurological disorders; we verify your policy directly via WhatsApp at +971 54 548 8731 before scheduling.
عدد كبير من شركات التأمين في الإمارات يشمل فحوص الجينات للأمراض العصبية الوراثية؛ نتحقق من تغطية التأمين مباشرة عبر واتساب على الرقم +971 54 548 8731 قبل أخذ العينة.
This service complies strictly with UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on healthcare practice, the 2026 CDS Law for protection of minors, and the UAE PDPL for medical data privacy. ISO 9001:2015 Certification: INT/EGQ/2509DA/3139.
Laboratory license: 9834453 | Clinical oversight: Dr. Prabhakar Reddy, DHA 61713011. © 2025 UAE Genomic Testing Center.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians